COVID-19: all 7,774 studies

Page 12 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• Therapeutic Plasma Exchange for COVID-19-associated HyperviscosityCompletedNCT04441996Phase 4Results posted
• Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19CompletedNCT04440007Phase 2Results posted
• A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)TerminatedNCT04439071Phase 2/3Results posted
• A Study of Ad26.COV2.S in Adults (COVID-19)CompletedNCT04436276Phase 1/2Results posted
• Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19TerminatedNCT04435808Phase 1/2Results posted
• Inhaled Ciclesonide for Outpatients With COVID19TerminatedNCT04435795Phase 2/3Results posted
• Crizanlizumab for Treating COVID-19 VasculopathyCompletedNCT04435184Phase 2Results posted
• Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19CompletedNCT04434131Phase 2Results posted
• Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 DiseaseTerminatedNCT04432298Phase 2Results posted
• ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)TerminatedNCT04432272Phase 2Results posted
• Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 SubjectsCompletedNCT04431908Results posted
• Study of Remdesivir in Participants Below 18 Years Old With COVID-19CompletedNCT04431453Phase 2/3Results posted
• Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDSCompletedNCT04429555Phase 2Results posted
• Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis PatientsCompletedNCT04428008Phase 2Results posted
• Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory CompromiseTerminatedNCT04427566Phase 2Results posted
• A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 IllnessCompletedNCT04427501Phase 2/3Results posted
• Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)CompletedNCT04427280Results posted
• Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19CompletedNCT04426695Phase 1/2Results posted
• Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 PandemicCompletedNCT04426006Not applicableResults posted
• Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19CompletedNCT04425863Results posted
• USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19CompletedNCT04425850Results posted
• Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19TerminatedNCT04425629Phase 3Results posted
• A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).CompletedNCT04425538Phase 2Results posted
• Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19CompletedNCT04425252Phase 1/2Results posted
• Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19TerminatedNCT04424901Phase 2Results posted
• Patients and Health Staff of Cancer Centres During the Covid-19 PandemicCompletedNCT04421625Not applicableResults posted
• A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19TerminatedNCT04421508Phase 3Results posted
• Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized PatientsCompletedNCT04421404Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Participants With COVID-19CompletedNCT04421027Phase 3Results posted
• Tofacitinib for Treatment of Moderate COVID-19TerminatedNCT04415151Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19CompletedNCT04412668Phase 2Results posted
• Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung InjuryCompletedNCT04412057Phase 2Results posted
• Study of Sargramostim in Patients With COVID-19CompletedNCT04411680Phase 2Results posted
• Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19CompletedNCT04411667Phase 4Results posted
• A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19CompletedNCT04411628Phase 1Results posted
• Aggrenox To Treat Acute Covid-19CompletedNCT04410328Phase 3Results posted
• Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 PatientsCompletedNCT04410159Phase 2Results posted
• Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)TerminatedNCT04409873Phase 2Results posted
• Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients TrialCompletedNCT04409834Phase 4Results posted
• Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)CompletedNCT04409509Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 PneumoniaCompletedNCT04409262Phase 3Results posted
• GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)TerminatedNCT04408183Phase 2Results posted
• Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)TerminatedNCT04406389Phase 4Results posted
• Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus DiseaseCompletedNCT04405999Phase 4Results posted
• Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19CompletedNCT04405570Phase 2Results posted
• PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without CancerTerminatedNCT04404361Phase 2Results posted
• Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19CompletedNCT04403880Results posted
• TD-0903 for ALI Associated With COVID-19CompletedNCT04402866Phase 2Results posted
• A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19CompletedNCT04402060Phase 1/2Results posted
• Adaptive COVID-19 Treatment Trial 2 (ACTT-2)CompletedNCT04401579Phase 3Results posted
• TXA127 for the Treatment of Severe COVID-19CompletedNCT04401423Phase 2Results posted
• Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 PatientsCompletedNCT04401293Phase 3Results posted
• Nigella Sativa in COVID-19CompletedNCT04401202Phase 2Results posted
• Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19TerminatedNCT04400890Phase 2Results posted
• Octagam 10% Therapy in COVID-19 Patients With Severe Disease ProgressionCompletedNCT04400058Phase 3Results posted
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammationCompletedNCT04399980Phase 2Results posted
• hCT-MSCs for COVID19 ARDSTerminatedNCT04399889Phase 1/2Results posted
• Niclosamide for Mild to Moderate COVID-19CompletedNCT04399356Phase 2Results posted
• Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19CompletedNCT04397939Results posted
• Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical VentilationTerminatedNCT04397796Phase 1Results posted
• COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.CompletedNCT04397757Phase 1Results posted
• Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring HospitalizationCompletedNCT04397718Phase 2Results posted
• Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer PatientsCompletedNCT04397614Not applicableResults posted
• Efficacy and Safety of COVID-19 Convalescent PlasmaCompletedNCT04397523Not applicableResults posted
• Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital SettingTerminatedNCT04396106Phase 2Results posted
• Home Usability Study of the SARS-CoV-2 (COVID-19) TestCompletedNCT04395391Results posted
• Trial of Imatinib for Hospitalized Adults With COVID-19TerminatedNCT04394416Phase 3Results posted
• ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19TerminatedNCT04393038Phase 2/3Results posted
• Colchicine Plus Phenolic Monoterpenes to Treat COVID-19CompletedNCT04392141Phase 1/2Results posted
• COVID-19 and Anti-CD14 Treatment TrialTerminatedNCT04391309Phase 2Results posted
• Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19CompletedNCT04391179Phase 2Results posted
• Convalescent Plasma for Early Treatment of COVID-19TerminatedNCT04390503Phase 2Results posted
• Early CPAP in COVID-19 Confirmed or Suspected PatientsTerminatedNCT04390191Not applicableResults posted
• Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal TrialCompletedNCT04390022Phase 2Results posted
• Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory FailureTerminatedNCT04389840Phase 2/3Results posted
• The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)CompletedNCT04389671Phase 2Results posted
• Inhaled Nitric Oxide for Preventing Progression in COVID-19TerminatedNCT04388683Phase 2Results posted
• COVID-19 Convalescent Plasma for Mechanically Ventilated PopulationCompletedNCT04388527Phase 1Results posted
• A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 PneumoniaCompletedNCT04386616Phase 2Results posted
• Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19TerminatedNCT04385849Phase 1Results posted
• Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 PandemicCompletedNCT04385238Results posted
• Convalescent Plasma for Patients With COVID-19CompletedNCT04385199Phase 2Results posted
• Zilucoplan® in Improving Oxygenation, Short-, Longterm Outcome of COVID19 Patients With Acute Hypoxic Respiratory FailureCompletedNCT04382755Phase 2Results posted
• Study of Efficacy and Safety of MAS825 in Patients With COVID-19CompletedNCT04382651Phase 2Results posted
• Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized ParticipantsCompletedNCT04382586Phase 2Results posted
• Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19CompletedNCT04382066Phase 1Results posted
• Study of Efficacy and Safety of DV890 in Patients With COVID-19 PneumoniaCompletedNCT04382053Phase 2Results posted
• A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving RadiotherapyTerminatedNCT04381988Phase 2Results posted
• Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 InfectionTerminatedNCT04381052Phase 2Results posted
• A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised AdultsCompletedNCT04380701Phase 1/2Results posted
• Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.CompletedNCT04380688Phase 2Results posted
• Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)CompletedNCT04380519Phase 2/3Results posted
• A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)CompletedNCT04379271Phase 2/3Results posted
• A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 PatientsCompletedNCT04377711Phase 3Results posted
• Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)CompletedNCT04377672Phase 1Results posted
• Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 InfectionTerminatedNCT04377659Phase 2Results posted
• Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)TerminatedNCT04377620Phase 3Results posted
• Fluoxetine to Reduce Intubation and Death After COVID19 InfectionCompletedNCT04377308Phase 4Results posted
• Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related DiseaseCompletedNCT04376684Phase 2Results posted
• HOPE Intervention for COVID-19CompletedNCT04376515Not applicableResults posted

← COVID-19 overview